Navigation Links
Rheumatoid Arthritis Can Be Costly

FRIDAY, March 15 (HealthDay News) -- Workers with rheumatoid arthritis have higher health care and other costs for U.S. employers than workers without the condition, a new study finds.

Rheumatoid arthritis is an autoimmune disease that causes pain, swelling, stiffness and loss of function in the joints, and can also affect other body organs.

The study appears in the March issue of the Journal of Occupational and Environmental Medicine.

Researchers analyzed an insurance-claims database to compare the costs to employers for more than 2,700 workers with rheumatoid arthritis and more than 338,000 workers without the condition. Their study included direct health care costs and indirect costs such as missed work days.

The study found that the average yearly cost for a worker with rheumatoid arthritis was $8,700, compared with $3,500 for a worker without the condition. Direct health care costs accounted for 90 percent of the extra $5,200 in the total yearly costs for a worker with arthritis, according to a journal news release.

The researchers also found that workers with rheumatoid arthritis averaged about three and a half more days of health-related work absences a year than those without arthritis. This included more sick days and more short-term disability time.

Based on their findings, the researchers calculated that workers with rheumatoid arthritis cost employers nationwide an additional $5.8 billion a year, compared to workers without it. Of that total, $5.2 billion is for direct health care costs. Workers with the condition also account for 4 million more lost work days per year than those without rheumatoid arthritis.

The study may underestimate the cost impact of rheumatoid arthritis for employers, particularly in reduced productivity, the researchers said.

"The data emphasize the need for effective management strategies that can reduce the burden of illness and economic losses incurred," concluded study co-author Richard Brook, of the JestaRx Group, which provides medical marketing services for clients in the pharmaceutical industry.

JestaRx has received funding from Abbott Laboratories. Two other study authors are employed by and own stock in Abbott, which makes drugs to treat rheumatoid arthritis, the study disclosed.

More information

The American Academy of Family Physicians has more about rheumatoid arthritis.

-- Robert Preidt

SOURCE: Journal of Occupational and Environmental Medicine, news release, March 2013

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Wide disparities in access to latest rheumatoid arthritis drugs across Europe
2. Salty Diet Might Help Trigger MS, Rheumatoid Arthritis
3. Newer Rheumatoid Arthritis Drugs Dont Seem to Increase Risk of Shingles
4. Sunshine Linked to Lower Rheumatoid Arthritis Risk: Study
5. Researchers uncover genes role in rheumatoid arthritis, findings pave way for new treatments
6. Newly approved oral medication slows rheumatoid arthritis joint damage
7. Genes and their regulatory tags conspire to promote rheumatoid arthritis
8. Complications challenge rheumatoid arthritis patients after joint replacement surgery
9. DNA May Explain Why Women Have More Rheumatoid Arthritis
10. Study: Rheumatoid Arthritis Plus Depression May Be Deadly
11. Extra Pounds Linked to Rheumatoid Arthritis Risk in Women
Post Your Comments:
Related Image:
Rheumatoid Arthritis Can Be Costly 
(Date:11/24/2015)... ... November 25, 2015 , ... ... Their Care Plan software creates an agreement between the practice owner and ... including financial, scheduling, monitoring, notification, and projections. Click here to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Charitable giving is at its peak during ... the last five weeks of the year totalling over $358 billion in 2014. ... the nation’s charities with those individuals who want to “give back” during the holidays. ...
(Date:11/24/2015)... ... 2015 , ... The hospitals and health systems on this ... care. They have received recognition for excellence from various reputable organizations in areas ... Hospital Review selected hospitals for inclusion based on national rankings and awards from ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 --> ... Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, welches ... innehaben, an Enyo Pharma vergeben haben. Im ... gerufenen und von Edelris gemeinsam mit seinen Partnern Inserm ... für HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, ...
(Date:11/24/2015)... , Nov. 25, 2015 WuXi PharmaTech ... ), a leading open-access R&D capability and technology platform ... with operations in China and ... that at an extraordinary general meeting of shareholders held ... proposal to authorize and approve the previously announced agreement ...
(Date:11/24/2015)... Nov. 24, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York.  The public is welcome to participate ... Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , ... 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
Breaking Medicine Technology: